Pharmacological evaluation of aqueous extract of syzigium cumini for its antihyperglycemic and antidyslipidemic properties in diabetic rats fed a high cholesterol diet—Role of PPARγ and PPARα

Biomedicine and Pharmacotherapy

Volumn 89, Issue , 2017, Pages 447-453

  Sharma, Sandhya ^a   Pathak, Sachchidanand ^b   Gupta, Gaurav ^c,d   Sharma, Satish Kumar ^a   Singh, Lalit ^a   Sharma, Rakesh Kumar ^b   Mishra, Anurag ^b   Dua, Kamal ^e,f,g  

^a Sunder Deep Group of Institutions   (India)

^b SURESH GYAN VIHAR UNIVERSITY   (India)

^c JAIPUR NATIONAL UNIVERSITY   (India)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^f UNIVERSITY OF NEWCASTLE   (Australia)

^g SHOOLINI UNIVERSITY   (India)

Author keywords

Antidiabetic; Antidyslipidemic; Metformin; Streptozotocin; Syzigium cumini

Indexed keywords

CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE; INSULIN; INSULIN SENSITIZING AGENT; LIPID; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUPEROXIDE DISMUTASE; SYZYGIUM CUMINI EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIDYSLIPIDEMIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BODY WEIGHT; CELL ULTRASTRUCTURE; CHOLESTEROL DIET; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG SCREENING; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIVER TISSUE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PLANT SEED; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SYZYGIUM CUMINI; ADMINISTRATION AND DOSAGE; ANIMAL; ANIMAL FOOD; BLOOD; CHEMISTRY; CHOLESTEROL INTAKE; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; FAT INTAKE; GENE EXPRESSION REGULATION; METABOLISM; SYZYGIUM; WISTAR RAT;

ANIMAL FEED; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL, DIETARY; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN; MALE; METFORMIN; PLANT EXTRACTS; PPAR ALPHA; PPAR GAMMA; RATS; RATS, WISTAR; SYZYGIUM;

EID: 85013937881     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.02.048     Document Type: Article

References (28)

1. [1] Spasov, A.A., et al. Study of antidiabetic activity of a new ultralow-dose antibody preparation on the model of streptozotocin diabetes in rats. Bull. Exp. Biol. Med. 144:1 (2007), 46–48.
2. [2] Babu, P.V., Liu, D., Gilbert, E.R., Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J. Nutr. Biochem. 24:11 (2013), 1777–1789.
3. [3] Rao, B.K., Kesavulu, M.M., Apparao, C., Antihyperglycemic activity of Momordica cymbalaria in alloxan diabetic rats. J. Ethnopharmacol. 78:1 (2001), 67–71.
4. [4] Rees, D.A., Alcolado, J.C., Animal models of diabetes mellitus. Diabet. Med. 22:4 (2005), 359–370.
5. [5] Bathina, S., Srinivas, N., Das, U.N., BDNF protects pancreatic beta cells (RIN5F) against cytotoxic action of alloxan: streptozotocin, doxorubicin and benzo(a)pyrene in vitro. Metabolism 65:5 (2016), 667–684.
6. [6] Masiello, P., et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47:2 (1998), 224–229.
7. [7] Oloyede, H.O., et al. Antidiabetic and antidyslipidemic activities of aqueous leaf extract of Dioscoreophyllum cumminsii (Stapf) Diels in alloxan-induced diabetic rats. J. Ethnopharmacol. 166 (2015), 313–322.
8. [8] Martinez, C.A., et al. Differential responses of superoxide dismutase in freezing resistant Solanum curtilobum and freezing sensitive Solanum tuberosum subjected to oxidative and water stress. Plant Sci. 160:3 (2001), 505–515.
9. [9] Prince, P.S., Kamalakkannan, N., Menon, V.P., Antidiabetic and antihyperlipidaemic effect of alcoholic Syzigium cumini seeds in alloxan induced diabetic albino rats. J. Ethnopharmacol. 91:2-3 (2004), 209–213.
10. [10] Stanely Mainzen Prince, P., Kamalakkannan, N., Menon, V.P., Syzigium cumini seed extracts reduce tissue damage in diabetic rat brain. J. Ethnopharmacol. 84:2-3 (2003), 205–209.
11. [11] Prince, P.S., Menon, V.P., Pari, L., Hypoglycaemic activity of Syzigium cumini seeds: effect on lipid peroxidation in alloxan diabetic rats. J. Ethnopharmacol. 61:1 (1998), 1–7.
12. [12] Trinder, P., Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 22:2 (1969), 158–161.
13. [13] Sharma, B., Balomajumder, C., Roy, P., Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats. Food Chem. Toxicol. 46:7 (2008), 2376–2383.
14. [14] Matthews, D.R., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:7 (1985), 412–419.
15. [15] Rotruck, J.T., et al. Selenium: biochemical role as a component of glutathione peroxidase. Science 179:4073 (1973), 588–590.
16. [16] Misra, H.P., Fridovich, I., The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247:10 (1972), 3170–3175.
17. [17] Hussain, R.M., Abdullah, N.F., Amom, Z., Killing of Staphylococcus aureus by allylpyrocatechol is potentiated by induction of intracellular oxidative stress and inhibition of catalase activity. J. Integr. Med. 14:6 (2016), 456–464.
18. [18] Sohet, F.M., et al. Lipid peroxidation is not a prerequisite for the development of obesity and diabetes in high-fat-fed mice. Br. J. Nutr. 102:3 (2009), 462–469.
19. [19] Bhatia, I.S., Bajaj, K.L., Chemical constituents of the seeds and bark of Syzygium cumini. Planta Med. 28:4 (1975), 346–352.
20. [20] Brito, F.A., et al. harmacological study of anti-allergic activity of Syzygium cumini (L.). Braz. J. Med. Biol. Res. 40:1 (2007), 105–115.
21. [21] Sáinz, N., et al. Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1α in ob/ob mice. PLoS One, 4(9), 2009, e6808.
22. [22] Chandra, D., et al. Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes. Diabetes 51:10 (2002), 3095–3101.
23. [23] Abalea, V., et al. Repair of iron-induced DNA oxidation by the flavonoid myricetin in primary rat hepatocyte cultures. Free Radic. Biol. Med. 26:11-12 (1999), 1457–1466.
24. [24] Beaumont, P., Madigan, M.C., Mathew, R.S., Crisis in optometric screening of diabetic retinopathy: illusion or reality. Clin. Exp. Ophthalmol. 39:3 (2011), 193–194.
25. [25] Chance, B., Greenstein, D.S., Roughton, F.J., The mechanism of catalase action. I. Steady-state analysis. Arch. Biochem. Biophys. 37:2 (1952), 301–321.
26. [26] Baynes, J.W., Role of oxidative stress in development of complications in diabetes. Diabetes 40:4 (1991), 405–412.
27. [27] Chaturvedi, A., et al. Ulcer healing properties of ethanolic extract of Eugenia jambolana seed in diabetic rats: study on gastric mucosal defensive factors. Indian J. Physiol. Pharmacol. 53:1 (2009), 16–24.
28. [28] Ayyanar, M., Subash-Babu, P., Syzygium cumini (L.) Skeels: a review of its phytochemical constituents and traditional uses. Asia. Pac. J. Trop. Biomed. 2:3 (2012), 240–246.